Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.56 | 1.36 |
NAV | ₹113.60 | ₹203.53 |
Fund Started | 31 Jan 2011 | 07 May 2007 |
Fund Size | ₹32069.13 Cr | ₹89383.23 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 12 months. | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 0.04% | 5.94% |
3 Year | 17.97% | 24.58% |
5 Year | 18.69% | 26.08% |
1 Year
3 Year
5 Year
Equity | 94.19% | 93.94% |
Cash | 0.01% | 6.06% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Fortis Healthcare Ltd. | 4.04% |
The Federal Bank Ltd. | 2.81% |
The Indian Hotels Company Ltd. | 2.50% |
JK Cement Ltd. | 2.41% |
Bharti Hexacom Ltd. | 2.39% |
GE Vernova T&D India Ltd | 2.32% |
Dixon Technologies (India) Ltd. | 2.10% |
UNO Minda Ltd. | 2.10% |
Multi Commodity Exchange Of India Ltd. | 2.06% |
Schaeffler India Ltd. | 1.96% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.46% |
AU Small Finance Bank Ltd. | 3.70% |
Indian Bank | 3.54% |
The Federal Bank Ltd. | 3.38% |
Balkrishna Industries Ltd. | 3.37% |
Fortis Healthcare Ltd. | 3.19% |
Coforge Ltd. | 3.11% |
Hindustan Petroleum Corporation Ltd. | 2.96% |
Glenmark Pharmaceuticals Ltd. | 2.67% |
Ipca Laboratories Ltd. | 2.52% |
Name | Vinayak Jayanath | Chirag Setalvad |
Start Date | 12 Dec 2023 | 28 Jun 2014 |
Name
Start Date
Description | The scheme seeks to achieve long term capital appreciation by investing predominantly in equity & equity related instruments of Mid Cap companies. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 31 Jan 2011 | 07 May 2007 |
Description
Launch Date